caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1760473722

Amy BolesMD

Family PracticeMankato, MNI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where Amy Boles's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
MAYO CLINIC HEALTH SYSTEM-SOUTHWEST MINNESOTA REGION56216
Mayo Collaborative Services, Inc
Clinical Laboratory · Rochester, MN
1145
THRO COMPANY1156
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
13,994
Beneficiaries
—
Total drug cost
$618K
Distinct drugs
162
Brand share
20.2%
Top prescribed drugs
Atorvastatin Calcium629 claims
Levothyroxine Sodium578 claims
Furosemide565 claims
Gabapentin552 claims
Warfarin Sodium505 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
546
Unique beneficiaries
—
Total services
924
Distinct HCPCS
13
Medicare payment
$48K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 2,349 Family Practice providers in MN — above median (cohort median 523).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.